Navigation Links
Chemo Alone Effective in Treating Kids' Brain Tumors
Date:10/10/2008

Delaying, avoiding radiation could lessen long-term side effects, study finds

FRIDAY, Oct. 10 (HealthDay News) -- Using chemotherapy alone, and delaying or avoiding radiation altogether, may be effective in treating children with inoperable or progressive low-grade glioma brain tumors, according to a multi-institutional study.

Low-grade glioma is the most common brain tumor in children. If surgery can be performed, the survival rate for patients is 95 percent. But prognosis is worse for children with tumors in locations that prevent surgical removal or with tumors that progress after surgery, according to background information in a news release about the study from the University of Texas M.D. Anderson Cancer Center in Houston.

Radiation is often used to treat children with inoperable or progressive low-grade gliomas. While radiation is often effective in treating these brain tumors, it can cause long-term effects such as mental impairment, hormonal deficiencies and increased risk of stroke later in life.

This new phase III study compared two different chemotherapy regimens, and confirmed that chemotherapy can be used to control inoperable or progressive low-grade gliomas in children, said principal investigator Dr. Joann Ater, a professor of pediatrics at the Children's Cancer Hospital at M.D. Anderson.

The study of 401 patients found that a regimen of thioguanine, procarbazine, lomustine and vincristine (TPCV) was more effective than a carboplatin and vincristine (VC) regimen and achieved a 5-year, event-free survival rate of almost 50 percent.

Patients aged 5 to 10 on the TPCV regimen averaged more than eight years without disease progression, compared to an average of 5.3 years among those who received the VC regimen. Patients younger than 5 on the VC regimen averaged 2.2 years before disease progression.

The study also found that chemotherapy was most effective among neurofibromatosis patients with low-grade gliomas.

"If we can delay radiation, then we allow more time for our youngest patients to develop physically, which could decrease some of the long-term effects from [radiation] treatment," Ater said. "This trial at least gives parents more information and alternative options when making decisions about their child's treatment."

The study was presented this week at the International Society of Pediatric Oncology annual meeting, in Berlin.

More information

The American Cancer Society has more about brain and spinal cord tumors in children.



-- Robert Preidt



SOURCE: M.D. Anderson Cancer Center, news release, Oct. 6, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Pneumatosis cystoids intestinalis after fluorouracil chemotherapy
2. Anti-angiogenic drugs impede chemotherapy-stimulated tumor recovery
3. Erectile dysfunction drugs allowed more chemotherapy to reach brain tumors in laboratory study
4. CSHL scientists correlate enzyme expression levels with chemotherapy drug response
5. Medicare Modernization Act not associated with major changes in access to chemotherapy
6. Data Published in Anticancer Research Show ChemoFx(R) Assay Results Correlate With Outcomes in Breast Cancer
7. Solid tumor cells not killed by radiation and chemotherapy become stronger
8. Avastin Added to Chemo Helps Women With Advanced Breast Cancer
9. Erbitux Plus Chemo Improves Lung Cancer Outcomes
10. Avastin Added to Chemo Helps Women With Advanced Cancer
11. Chemo May Limit Fertility in Breast Cancer Survivors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... ... BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a ... an hour by 2020 and then adjusting it yearly to increase at the same rate ... assure the wage floor does not erode again, and make future increases more predictable. , ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Global MEMS Devices Medical Market Analysis 2016 - Forecast to ... The report contains up to date financial ... reliable analysis. Assessment of major trends with potential impact on ... dive analysis of market segmentation which comprises of sub markets, ...
(Date:6/23/2016)... , , , WHEN: , , ... , , , LOCATION: , , , Online, with free registration ... PANELISTS:  , , , Frost & Sullivan,s Global Vice President of ... Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... witnessing an exceptional era. Several new demand spaces, such as innovative ...
Breaking Medicine Technology: